Modern Chinese Medicine Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG6181B1068
HKD
2.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lee's Pharmaceutical Holdings Ltd.
Pak Fah Yeow International Ltd.
Modern Chinese Medicine Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Antengene Corp. Ltd.
Clover Biopharmaceuticals Ltd.
China Biotech Services Holdings Ltd.
CANbridge Pharmaceuticals Inc.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Lansen Pharmaceutical Holdings Ltd.
Tianda Pharmaceuticals Ltd.

Why is Modern Chinese Medicine Group Co., Ltd. ?

1
High Debt company with Weak Long Term Fundamental Strength
2
The company has declared Negative results for the last 4 consecutive quarters
  • INTEREST COVERAGE RATIO(Q) Lowest at 268,266.8
  • RAW MATERIAL COST(Y) Grown by 24.87% (YoY)
  • NET SALES(Q) Lowest at HKD 69.56 MM
3
With ROE of 2.04%, it has a Very Expensive valuation with a 0.82 Price to Book Value
  • Over the past year, while the stock has generated a return of 528.13%, its profits have fallen by -80.6%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Modern Chinese Medicine Group Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Modern Chinese Medicine Group Co., Ltd.
528.12%
4.42
98.69%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-22.26%
EBIT Growth (5y)
-45.52%
EBIT to Interest (avg)
97.34
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.74
Tax Ratio
34.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
52.73%
ROE (avg)
14.49%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
0.81
EV to EBIT
6.70
EV to EBITDA
4.82
EV to Capital Employed
0.65
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.64%
ROE (Latest)
2.04%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
PRE-TAX PROFIT(Q)

At HKD 3.68 MM has Grown at 178.56%

NET PROFIT(Q)

At HKD 2.63 MM has Grown at 135.49%

DEBTORS TURNOVER RATIO(HY)

Highest at 6.68 times

-5What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 268,266.8

RAW MATERIAL COST(Y)

Grown by 24.87% (YoY

NET SALES(Q)

Lowest at HKD 69.56 MM

Here's what is working for Modern Chinese Medicine Group Co., Ltd.

Pre-Tax Profit
At HKD 3.68 MM has Grown at 178.56%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit
At HKD 2.63 MM has Grown at 135.49%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (HKD MM)

Debtors Turnover Ratio
Highest at 6.68 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Modern Chinese Medicine Group Co., Ltd.

Interest Coverage Ratio
Lowest at 268,266.8
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales
Lowest at HKD 69.56 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Raw Material Cost
Grown by 24.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales